Statistics

Total Visits

Views
Value of serum epidermal growth factor receptor in the selection of patients with non-small-cell lung cancer to be treated with the tyrosine kinase inhibitor erlotinib30

Select a period of time:

Number of views in the range

Views
Value of serum epidermal growth factor receptor in the selection of patients with non-small-cell lung cancer to be treated with the tyrosine kinase inhibitor erlotinib20

Views

Views
October 20240
November 20241
December 20240
January 20251
February 20251
March 202516
April 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United Kingdom2
United States2
 

Top cities views

Views